Lung function in men with and without HIV
- PMID: 32287070
- PMCID: PMC7362901
- DOI: 10.1097/QAD.0000000000002526
Lung function in men with and without HIV
Abstract
Objectives: Initial studies suggest HIV-positive persons may be at increased risk for chronic lung diseases such as chronic obstructive pulmonary disease, but have commonly relied on single-center designs, lacked HIV-negative controls, or assessed lung function with only spirometry. We tested differences in spirometry and single-breath diffusing capacity for carbon monoxide (DLCO) in persons with and without HIV.
Design: Cross-sectional, observational study.
Methods: Participants were enrolled from the Multicenter AIDS Cohort Study, a longitudinal cohort study of men who have sex with men (both HIV-positive and HIV-negative) at four sites in the United States. Standardized spirometry and DLCO testing were performed in all eligible, consenting participants at routine study visits. We tested associations between HIV status and spirometry and DLCO results, using linear and logistic regression.
Results: Among 1067 men, median age was 57 years, prevalence of current marijuana (30%), and cigarette (24%) use was high, and another 45% were former cigarette smokers. Median forced expiratory volume in 1 s was 97% of predicted normal and DLCO was 85% of predicted normal. HIV-positive persons demonstrated no statistical difference in forced expiratory volume in 1 s compared with HIV-negative persons, but had worse DLCO (adjusted difference -2.6% of predicted; 95% confidence interval: -4.7 to -0.6%) and a higher risk of DLCO impairment (odds ratio for DLCO < 60% of predicted 2.97; 95% confidence interval: 1.36-6.47). Lower DLCO was associated with lower nadir CD4 cell counts.
Conclusion: HIV-positive men are at increased risk of abnormal gas exchange, indicated by low DLCO, compared with men without HIV.
Conflict of interest statement
Conflicts of interest
All authors have received grant support from NIH for the work presented here. K.M.K. has received consultancy fees from GlaxoSmithKline and Nuvaira, Inc. outside the work presented here; has received contracted clinical trial support from AstraZeneca and Sanofi outside the work presented here. R.J. has received consultancy fees from ndd Medical Technologies. D.C., G.D., M.E.F., V.S., and A.M.: nothing to declare. M.C.M. has received consultancy fees from GlaxoSmithKline and royalties from UpToDate outside the work presented here.
Figures
![Fig. 1.](https://webcf.waybackmachine.org/web/20220408220656im_/https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7362901/bin/nihms-1606828-f0001.gif)
Similar articles
-
Recent advances in HIV-associated chronic lung disease clinical research.Curr Opin HIV AIDS. 2021 May 1;16(3):156-162. doi: 10.1097/COH.0000000000000679. Curr Opin HIV AIDS. 2021. PMID: 33797432 Review.
-
Pulmonary function tests in HIV-infected patients without AIDS. Pulmonary Complications of HIV Infection Study Group.Am J Respir Crit Care Med. 1995 Aug;152(2):738-45. doi: 10.1164/ajrccm.152.2.7633736. Am J Respir Crit Care Med. 1995. PMID: 7633736
-
Lung function in former intravenous drug abusers: the effect of ubiquitous cigarette smoking.Am J Med. 1991 Jun;90(6):678-84. Am J Med. 1991. PMID: 2042683
-
HIV infection is associated with reduced pulmonary diffusing capacity.J Acquir Immune Defic Syndr. 2013 Nov 1;64(3):271-8. doi: 10.1097/QAI.0b013e3182a9215a. J Acquir Immune Defic Syndr. 2013. PMID: 23979001 Free PMC article.
-
Office-based DLCO tests help pulmonologists to make important clinical decisions.Respir Investig. 2016 Sep;54(5):305-11. doi: 10.1016/j.resinv.2016.03.006. Epub 2016 May 2. Respir Investig. 2016. PMID: 27566377 Review.
Cited by 8 articles
-
Dyspnea and Pulmonary Function Among Participants in the Multicenter AIDS Cohort Study Using Protease Inhibitors: A Cross-Sectional Study.AIDS Res Hum Retroviruses. 2022 Feb;38(2):143-151. doi: 10.1089/AID.2021.0082. AIDS Res Hum Retroviruses. 2022. PMID: 34969258
-
World AIDS Day: 40 years of an evolving pulmonary landscape.Am J Physiol Lung Cell Mol Physiol. 2021 Dec 1;321(6):L1059-L1061. doi: 10.1152/ajplung.00457.2021. Epub 2021 Nov 10. Am J Physiol Lung Cell Mol Physiol. 2021. PMID: 34755570 No abstract available.
-
Brief Report: HIV Is Associated With Impaired Pulmonary Diffusing Capacity Independent of Emphysema.J Acquir Immune Defic Syndr. 2022 Jan 1;89(1):64-68. doi: 10.1097/QAI.0000000000002818. J Acquir Immune Defic Syndr. 2022. PMID: 34560768 Free PMC article.
-
Brief Report: Association Between Pain, Pulmonary Function, and Respiratory Symptoms in People With HIV.J Acquir Immune Defic Syndr. 2021 Aug 15;87(5):1161-1166. doi: 10.1097/QAI.0000000000002696. J Acquir Immune Defic Syndr. 2021. PMID: 33871410
-
Recent advances in HIV-associated chronic lung disease clinical research.Curr Opin HIV AIDS. 2021 May 1;16(3):156-162. doi: 10.1097/COH.0000000000000679. Curr Opin HIV AIDS. 2021. PMID: 33797432 Review.
Publication types
MeSH terms
Substances
Grant support
- U01 HL146245/HL/NHLBI NIH HHS/United States
- U01 HL146205/HL/NHLBI NIH HHS/United States
- U01 HL146208/HL/NHLBI NIH HHS/United States
- U01 HL146192/HL/NHLBI NIH HHS/United States
- U01 HL146242/HL/NHLBI NIH HHS/United States
- UM1 AI035043/AI/NIAID NIH HHS/United States
- U01 HL146201/HL/NHLBI NIH HHS/United States
- U01 HL146193/HL/NHLBI NIH HHS/United States
- U01 AI035039/AI/NIAID NIH HHS/United States
- U01 HL146194/HL/NHLBI NIH HHS/United States
- U01 HL146241/HL/NHLBI NIH HHS/United States
- P30 AI027767/AI/NIAID NIH HHS/United States
- P30 AI050409/AI/NIAID NIH HHS/United States
- U01 HL146333/HL/NHLBI NIH HHS/United States
- U01 HL146204/HL/NHLBI NIH HHS/United States
- U01 HL146202/HL/NHLBI NIH HHS/United States
- UL1 TR000004/TR/NCATS NIH HHS/United States
- U01 HL146240/HL/NHLBI NIH HHS/United States
- U01 HL146203/HL/NHLBI NIH HHS/United States
- P30 AI050410/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials